Top search result for "Komzifti" in Treatments. To see all results and access other features, sign up for free.

Komzifti (Ziftomenib)

Overview
Komzifti is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with relapsed or refractory acute myeloid leukemia (AML) that carries a susceptible nucleophosmin 1 (NPM1) mutation…

MyLeukemiaTeam is the social network for those living with leukemia. Get the emotional support you need from others like you, and gain practical advice and insights on managing treatment or therapies for leukemia. MyLeukemiaTeam is the only social network where you can truly connect, make real friendships, and share daily ups and downs in a judgement-free place.

MyLeukemiaTeam is not a medical referral site and does not recommend or endorse any particular provider or medical treatment. No information on MyLeukemiaTeam should be construed as medical and/or health advice.

Your Privacy is Our Priority

Connect with others who understand.

Top search result for "Komzifti" in Treatments. To see all results and access other features, sign up for free.

Komzifti (Ziftomenib)